CD9 and posterior cortical atrophy: However, the uEVEpCAM-CD9 from even down to 125 μl of urine volume could be successfully detected by our CLIA, and the levels of uEVEpCAM-CD9 in the same urine volume were statistically distinguishable between the pooled samples from PCa and healthy controls (Figures 3B, C).